17 results
20-F/A
2023 FY
BLRX
Bioline Rx Ltd
26 Mar 24
Annual report (foreign) (amended)
4:57pm
other countries and bulk purchasing. For example, in recent years, several states have formed prescription drug affordability boards (PDABs). Much … an affordability review. The effects of these efforts remain uncertain pending the outcomes of several federal lawsuits challenging state authority
6-K
EX-99
BLRX
Bioline Rx Ltd
12 Oct 23
BioLineRx Announces Closing of Exclusive License Agreement to Motixafortide
7:14am
immunotherapies and biologics for oncology. Toward the company’s ultimate goal of improving accessibility, affordability, and availability for patients
20-F/A
2014 FY
BLRX
Bioline Rx Ltd
23 Mar 15
Annual report (foreign) (amended)
12:00am
by the Health Care and Education Affordability Reconciliation Act (collectively, the PPACA), important legislation regarding health insurance which
424B5
h82pkm6aahqzgj k21k
6 Mar 15
Prospectus supplement for primary offering
12:00am
424B5
7xa wze44d
5 Mar 15
Prospectus supplement for primary offering
12:00am
6-K
EX-99.3
1vaqavmya 2kwejkii7f
5 Mar 15
Current report (foreign)
12:00am
424B2
18o9i4
13 Jun 14
Prospectus for primary offering
12:00am
F-3
4b1jt hjl7nv
30 May 14
Shelf registration (foreign)
12:00am
424B5
0dilfx4 f30tr
4 Mar 14
Prospectus supplement for primary offering
12:00am
6-K
EX-99.3
fzcwwmqz687dc
3 Mar 14
Current report (foreign)
12:00am
424B5
q6orw lyb
3 Mar 14
Prospectus supplement for primary offering
12:00am
424B3
s10x75
8 Aug 13
Prospectus supplement
12:00am
424B5
ulr fothtnphubuswud
6 Feb 13
Prospectus supplement for primary offering
12:00am
- Prev
- 1
- Next